Sign Up to like & get
recommendations!
0
Published in 2021 at "Drug development research"
DOI: 10.1002/ddr.21819
Abstract: Sumatriptan is the first available medication from triptans family that was approved by the U.S. Food and Drug Administration for migraine attacks and cluster headaches in 1991. Most of its action is mediated by selective…
read more here.
Keywords:
anti inflammatory;
migraine;
sumatriptan;
systematic review ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Life sciences"
DOI: 10.1016/j.lfs.2019.116901
Abstract: AIMS Allergic rhinitis is a global cause of disability, characterized by airway inflammation. Sumatriptan is a 5-hydroxytryptamine 1B/1D (5HT1B/1D) agonist used as a treatment for migraine headaches. Activation of 5HT1B/1D receptors can inhibit the release…
read more here.
Keywords:
allergic rhinitis;
sumatriptan;
ovalbumin induced;
induced allergic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2018.1390563
Abstract: ABSTRACT Introduction: AVP-825 (sumatriptan nasal powder) is an FDA-approved intranasal medication delivery system containing low-dose sumatriptan powder for acute treatment of migraine with or without aura in adults. AVP-825 utilizes unique nasal anatomy features to…
read more here.
Keywords:
migraine;
sumatriptan;
delivery;
nasal ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biosensors"
DOI: 10.3390/bios12100872
Abstract: In this work, Ni-Co layered double hydroxide (Ni–Co LDH) hollow nanostructures were synthesized and characterized by X-ray diffraction (XRD), field emission-scanning electron microscopy (FE-SEM), and Fourier-transform infrared spectroscopy (FT-IR) techniques. A screen-printed electrode (SPE) surface…
read more here.
Keywords:
layered double;
hollow nanostructures;
double hydroxide;
sumatriptan naproxen ... See more keywords